MedPath

Flavoxate Hydrochloride

Flavoxate Hydrochloride Tablets, 100 mg Film-Coated

Approved
Approval ID

e05f4892-0be8-4178-a274-3289edca0137

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 25, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flavoxate hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6326
Application NumberANDA076835
Product Classification
M
Marketing Category
C73584
G
Generic Name
Flavoxate hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 25, 2012
FDA Product Classification

INGREDIENTS (9)

dibasic calcium phosphate dihydrateInactive
Code: O7TSZ97GEP
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
Flavoxate hydrochlorideActive
Quantity: 100 mg in 1 1
Code: 9C05J6089W
Classification: ACTIB
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
hypromellosesInactive
Code: 3NXW29V3WO
Classification: IACT
polydextroseInactive
Code: VH2XOU12IE
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Flavoxate Hydrochloride - FDA Drug Approval Details